title: Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies.
abstract: OBJECTIVE
  Standardized uptake values (SUV) are commonly used for quantification of whole-body [(18)F]fluoro-2-deoxy-D: -glucose (FDG) positron emission tomography (PET) studies. Changes in SUV following therapy, however, only provide a proper measure of response in case of homogeneous FDG uptake in the tumour. The purpose of this study was therefore to implement and characterize a method that enables quantification of heterogeneity in tumour FDG uptake.
  
  
  METHODS
  Cumulative SUV-volume histograms (CSH), describing % of total tumour volume above % threshold of maximum SUV (SUV(max)), were calculated. The area under a CSH curve (AUC) is a quantitative index of tumour uptake heterogeneity, with lower AUC corresponding to higher degrees of heterogeneity. Simulations of homogeneous and heterogeneous responses were performed to assess the value of AUC-CSH for measuring uptake and/or response heterogeneity. In addition, partial volume correction and image denoising was applied prior to calculating AUC-CSH. Finally, the method was applied to a number of human FDG scans.
  
  
  RESULTS
  Partial volume correction and noise reduction improved CSH curves. Both simulations and clinical examples showed that AUC-CSH values corresponded with level of tumour heterogeneity and/or heterogeneity in response. In contrast, this correspondence was not seen with SUV(max) alone. The results indicate that the main advantage of AUC-CSH above other measures, such as 1/COV (coefficient of variation), is the possibility to measure or normalize AUC-CSH in different ways.
  
  
  CONCLUSIONS
  AUC-CSH might be used as a quantitative index of heterogeneity in tracer uptake. In response monitoring studies it can be used to address heterogeneity in response.
authors: Department of Nuclear Medicine & PET Research, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands. f.vvelden@vumc.nl
authors: Floris H P
authors: FH
authors: van Velden
authors: Patsuree
authors: P
authors: Cheebsumon
authors: Maqsood
authors: M
authors: Yaqub
authors: Egbert F
authors: EF
authors: Smit
authors: Otto S
authors: OS
authors: Hoekstra
authors: Adriaan A
authors: AA
authors: Lammertsma
authors: Ronald
authors: R
authors: Boellaard
references: Eur J Cancer. 2007 Jun;43(9):1392-8
references: 17512190
references: J Nucl Med. 2007 May;48(5):802-10
references: 17475970
references: Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):854-61
references: 15936570
references: Eur J Nucl Med Mol Imaging. 2010 Aug;37(9):1679-87
references: 20422184
references: J Nucl Med. 2005 Aug;46(8):1342-8
references: 16085592
references: J Nucl Med. 2001 Jan;42(1):9-16
references: 11197987
references: J Nucl Med. 2008 Dec;49(12):1973-9
references: 18997052
references: Eur J Nucl Med Mol Imaging. 2007 Sep;34(9):1427-38
references: 17431616
references: Eur J Nucl Med Mol Imaging. 2003 Feb;30(2):274-80
references: 12552346
references: Clin Positron Imaging. 1999 May;2(3):159-171
references: 14516540
references: Med Phys. 2010 Sep;37(9):4902-15
references: 20964209
references: Phys Med Biol. 2011 Feb 21;56(4):881-901
references: 21248393
references: J Comput Assist Tomogr. 2002 Mar-Apr;26(2):185-90
references: 11884771
references: Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):545-53
references: 15890599
references: Clin Lung Cancer. 2003 Jan;4(4):242-7
references: 14624714
references: Int J Radiat Oncol Biol Phys. 1991 May 15;21(1):71-8
references: 2032898
references: Radiother Oncol. 2008 Apr;87(1):55-8
references: 18328584
references: Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1636-47
references: 21617975
references: Biostatistics. 2005 Apr;6(2):293-301
references: 15772107
references: Radiother Oncol. 2006 Nov;81(2):209-25
references: 17064802
references: J Nucl Med. 2005 Apr;46(4):675-82
references: 15809491
references: Biostatistics. 2003 Jul;4(3):433-48
references: 12925510
references: J Nucl Med. 2004 Sep;45(9):1519-27
references: 15347719
references: Pattern Recognit. 2009 Jun 1;42(6):1162-1171
references: 20161266
references: J Nucl Med. 2007 Mar;48(3):471-80
references: 17332626